GlassScriptPhysician profile
Sami Alaraj
NPI 1134797764
$6,068.51
in general payments reported to CMS, 2019-2025
12 companies · $4,200 in 2025
The $4,200 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $195 · 2023: $713 · 2024: $452 · 2025: $4,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176 · Travel and Lodging: $2,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.85 |
| Travel and Lodging | $2,188.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $2,982.58 | 2025 | |
| Stryker Corporation | $1,415.14 | 2021-2025 | Mako, T2, Prophecy |
| Medinc of Texas | $421.74 | 2025 | |
| Medical Device Business Services, INC. | $345.81 | 2021 | |
| Depuy Synthes Sales INC. | $186.83 | 2025 | Motoband, Na |
| Axogen | $177.92 | 2024-2025 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Alafair Biosciences, INC. | $159.49 | 2025 | Versawrap |
| Sanara Medtech INC. | $147.93 | 2023 | Celleraterx |
| Linvatec Corporation | $112.42 | 2025 | Biobrace 23mm |
| Globus Medical, INC. | $63.34 | 2024 | Creo Threaded |
| Vertex Pharmaceuticals Incorporated | $33.94 | 2025 | |
| Bioventus LLC | $21.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Alaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.